FDA

News

FDA rejects Novartis' cholesterol drug after factory inspect...

Novartis’ cholesterol drug inclisiran has hit a speed bump with the FDA, which has rejected the potential blockbuster because a manufacturing facility has yet to be inspected.

News

Glass Medicine Vials and botox, hualuronic, collagen or flu Syringe on a white background.

Moderna’s COVID-19 vaccine is second for US after FDA green ...

As expected, the FDA has moved swiftly ahead with emergency approval of Moderna’s COVID-19 vaccine after a positive assessment at its vaccines advisory committee.

News

FDA aims for fast approval of Moderna's COVID-19 shot after ...

The FDA is looking to quickly approve Moderna’s COVID-19 vaccine after it was unanimously backed by a panel of experts.

News

Photographs of 400mg and 120mg vials of Benlysta and packaging for Human Genome Sciences on 3/21/11.

GSK’s Benlysta claims first FDA okay for lupus kidney damage

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up its sleeve – it’s just become the first and only FDA-approved treatment for lupus neph

News

Entresto set for big sales hike after FDA panel endorsement

Novartis’ Entresto is on course to become the first drug to be approved in the US for a form of heart failure that is notoriously hard to treat effectively, despite missing the mark in a ph

News

FDA backs Moderna COVID-19 shot ahead of emergency use vote

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its effica

FDA rejects Novartis' cholesterol drug after factory inspect...

Moderna’s COVID-19 vaccine is second for US after FDA green ...

FDA aims for fast approval of Moderna's COVID-19 shot after ...

GSK’s Benlysta claims first FDA okay for lupus kidney damage

Entresto set for big sales hike after FDA panel endorsement

FDA backs Moderna COVID-19 shot ahead of emergency use vote

Grail cancer test gets lukewarm backing from FDA adcomm

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks